EDGAR Filing Documents for 0001493152-23-038912

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001493152-23-038912

Filing Date

2023-11-01

Accepted

2023-10-31 17:55:47

Documents

Effectiveness Date

2023-11-01

Items

Item 06c:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	7477
	Complete submission text file	0001493152-23-038912.txt		8537

Mailing Address 194 CANDELERO DRIVE SUITE 223 HUMACAO PR 00791

Business Address 194 CANDELERO DRIVE SUITE 223 HUMACAO PR 00791 (415)-592-7399

Aspire BioPharma, Inc. (Filer) CIK: 0001995528 (see all company filings)